Search results for:
bevacizumab
bevacizumab
| Drug Name |
Form |
Strength |
Notes |
| Avastin |
SOLUTION, INTRAVENOUS |
25 mg/mL |
|
| Alymsys |
SOLUTION, INTRAVENOUS |
maly 25 mg/mL |
|
| Jobevne |
SOLUTION, INTRAVENOUS |
nwgd 25 mg/mL |
|
| Mvasi |
SOLUTION, INTRAVENOUS |
awwb 25 mg/mL |
|
| Vegzelma |
SOLUTION, INTRAVENOUS |
adcd 25 mg/mL |
|
| Zirabev |
SOLUTION, INTRAVENOUS |
bvzr 25 mg/mL |
|
Last updated: Mar. 12, 2026
This medication is Inpatient Non-formulary and Restricted to Outpatient Use. Inpatient use requires approval by a physician department leader (ie Medical Director or Chair, or hospital CMO) collaborating with a pharmacy leader.
See HERE for more information and workflow.
See HERE for additional pharmacy workflow details.